Filings & corporate actions
79 results filed
CSVNext results · Q2 FY27
Expected 23 Oct 2026 – 8 Nov 2026
Estimate: filed 23–39 days after quarter end, last 5 times
Dividend
₹2.00 per share · last 18 Jun 2026
2026
- 20 JulshareholdingShareholding · 30 Jun 2026-5.2%NSE
- 20 JulresultsResults · Q1 FY27 · standalone+13.1%NSE
- 18 JundividendDividend · ₹2.00 per share+4.3%
- 6 MayresultsResults · Q4 FY26 · standalone-0.9%NSE
- 21 AprshareholdingShareholding · 31 Mar 2026-0.7%NSE
- 28 JanresultsResults · Q3 FY26 · standalone-10.3%NSE
- 20 JanshareholdingShareholding · 31 Dec 2025-4.0%NSE
Reaction to results · all yearsrose on day 0 in 36 of 77 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q1 FY27 | 20 Jul 2026 | +13.1% | +13.5% | +17.2% | 24.7× |
| Q4 FY26 | 6 May 2026 | -0.9% | -9.8% | +6.6% | 13.3× |
| Q3 FY26 | 28 Jan 2026 | -10.3% | -13.9% | -9.2% | 5.6× |
| Q2 FY26 | 3 Nov 2025 | -3.1% | -5.6% | -10.4% | 1.2× |
| Q1 FY26 | 17 Jul 2025 | +12.7% | +25.5% | +42.5% | 67.8× |
| Q4 FY25 | 29 Apr 2025 | +1.1% | -5.1% | -4.5% | 2.4× |
| Q3 FY25 | 24 Jan 2025 | -4.6% | +0.6% | +8.7% | 2.2× |
| Q2 FY25 | 8 Nov 2024 | +6.9% | +7.0% | +32.4% | 17.1× |
| Q1 FY25 | 17 Jul 2024 | -5.1% | -2.5% | -11.6% | 2.0× |
| Q4 FY24 | 18 May 2024 | -3.3% | -2.5% | -1.9% | 0.3× |
| Q3 FY24 | 31 Jan 2024 | +0.7% | +11.2% | +12.0% | 5.5× |
| Q2 FY24 | 30 Oct 2023 | +0.9% | -6.3% | -7.7% | 3.7× |
| Q1 FY24 | 28 Jul 2023 | -8.2% | -7.8% | +16.3% | 2.0× |
| Q4 FY23 | 3 May 2023 | +0.5% | +1.9% | +8.3% | 2.8× |
| Q3 FY23 | 27 Jan 2023 | -10.5% | -17.9% | -25.2% | 5.3× |
| Q2 FY23 | 27 Oct 2022 | +3.2% | +15.2% | +15.8% | 3.4× |
| Q4 FY22 | 12 May 2022 | +3.3% | +3.1% | -0.6% | 2.4× |
| Q3 FY22 | 20 Jan 2022 | -4.5% | -10.5% | -17.1% | 2.8× |
| Q2 FY22 | 23 Oct 2021 | +4.9% | +20.4% | +27.8% | 3.9× |
| Q1 FY22 | 22 Jul 2021 | -3.7% | -3.4% | -16.9% | 0.8× |
| Q4 FY21 | 14 May 2021 | -4.0% | -14.6% | +8.0% | 0.8× |
| Q3 FY21 | 23 Jan 2021 | -2.5% | +2.7% | -1.8% | 1.1× |
| Q2 FY21 | 15 Oct 2020 | +5.0% | +2.8% | +0.6% | 2.8× |
| Q1 FY21 | 10 Aug 2020 | -1.4% | -5.7% | -9.2% | 0.8× |
| Q4 FY20 | 15 Jun 2020 | +3.0% | +8.4% | +9.9% | 2.0× |
| Q3 FY20 | 30 Jan 2020 | +12.7% | +17.3% | -7.2% | 16.2× |
| Q2 FY20 | 9 Nov 2019 | -19.6% | -26.1% | -24.1% | 11.6× |
| Q1 FY20 | 29 Jul 2019 | -15.0% | -24.4% | -33.5% | 4.5× |
| Q4 FY19 | 21 May 2019 | +1.2% | -0.3% | -15.5% | 1.0× |
| Q3 FY19 | 19 Feb 2019 | -1.7% | -6.2% | -2.3% | 0.9× |
| Q2 FY19 | 20 Nov 2018 | -2.3% | +0.9% | +22.2% | 1.3× |
| Q1 FY19 | 23 Aug 2018 | +0.5% | +15.7% | +13.7% | 0.2× |
| Q4 FY18 | 19 Jun 2018 | -5.9% | -9.2% | -8.5% | 2.6× |
| Q3 FY18 | 9 Feb 2018 | +1.6% | +4.3% | +0.2% | 0.1× |
| Q2 FY18 | 4 Dec 2017 | -2.0% | -3.7% | +3.2% | 12.8× |
| Q1 FY18 | 23 Aug 2017 | -0.2% | +1.7% | +0.8% | 0.9× |
| Q4 FY17 | 23 Jun 2017 | +4.0% | +11.5% | +15.3% | 4.3× |
| Q3 FY17 | 13 Feb 2017 | +3.8% | +1.8% | +3.7% | 3.1× |
| Q2 FY17 | 18 Nov 2016 | -1.2% | -2.2% | -1.9% | 0.2× |
| Q1 FY17 | 14 Jul 2016 | +11.7% | +15.7% | +4.5% | 69.2× |
| Q4 FY16 | 17 May 2016 | +2.4% | -5.5% | -5.0% | 0.8× |
| Q3 FY16 | 1 Feb 2016 | 0.0% | -9.8% | -23.2% | 0.4× |
| Q2 FY16 | 7 Nov 2015 | +7.8% | +19.6% | +31.1% | 1.2× |
| Q1 FY16 | 20 Jul 2015 | -4.7% | -5.2% | -7.7% | 0.8× |
| Q4 FY15 | 28 May 2015 | +0.3% | +5.5% | +11.0% | 0.7× |
| Q3 FY15 | 10 Feb 2015 | +1.3% | +1.9% | +1.3% | 0.6× |
| Q2 FY15 | 14 Nov 2014 | -2.8% | -4.1% | -21.9% | 1.0× |
| Q1 FY15 | 1 Aug 2014 | +0.4% | -4.0% | -1.0% | 0.5× |
| Q4 FY14 | 20 May 2014 | +6.8% | -3.0% | -9.8% | 0.7× |
| Q3 FY14 | 27 Jan 2014 | +3.4% | +5.1% | +18.6% | 1.1× |
| Q2 FY14 | 7 Nov 2013 | +4.1% | +20.5% | +28.4% | 2.3× |
| Q1 FY14 | 17 Jul 2013 | +3.7% | -6.7% | -9.0% | 5.2× |
| Q4 FY13 | 21 May 2013 | -1.4% | -2.3% | -4.1% | 0.2× |
| Q3 FY13 | 4 Feb 2013 | -4.0% | -10.0% | -20.0% | 0.8× |
| Q2 FY13 | 5 Nov 2012 | +4.9% | +14.8% | +3.8% | 0.3× |
| Q1 FY13 | 17 Jul 2012 | -3.9% | -1.3% | +4.4% | 2.3× |
| Q4 FY12 | 22 May 2012 | -2.9% | +0.7% | -4.3% | 0.5× |
| Q3 FY12 | 30 Jan 2012 | -5.6% | -6.1% | -6.1% | 1.7× |
| Q2 FY12 | 31 Oct 2011 | -4.3% | -8.6% | -26.3% | 1.4× |
| Q1 FY12 | 23 Jul 2011 | -3.1% | -7.9% | -28.9% | 0.7× |
| Q4 FY11 | 13 May 2011 | +1.4% | -1.4% | +52.5% | 0.6× |
| Q3 FY11 | 31 Jan 2011 | +2.5% | -2.1% | -15.8% | 1.4× |
| Q2 FY11 | 29 Oct 2010 | -0.2% | -3.9% | -26.3% | 0.2× |
| Q1 FY11 | 28 Jul 2010 | -9.8% | -13.0% | -15.6% | 1.7× |
| Q4 FY10 | 12 May 2010 | +5.4% | +4.7% | -1.6% | 2.3× |
| Q3 FY10 | 25 Jan 2010 | -4.8% | -13.9% | -27.4% | 0.5× |
| Q2 FY10 | 22 Oct 2009 | -3.5% | -13.2% | -20.3% | 1.2× |
| Q1 FY10 | 23 Jul 2009 | -0.7% | -9.1% | -7.6% | 0.4× |
| Q4 FY09 | 28 Apr 2009 | -5.6% | -2.1% | +51.3% | 0.4× |
| Q3 FY09 | 16 Jan 2009 | -14.5% | -28.6% | -27.9% | 2.3× |
| Q2 FY09 | 30 Oct 2008 | -10.5% | +7.4% | +7.4% | 12.1× |
| Q1 FY09 | 30 Jul 2008 | +1.3% | +8.1% | -0.8% | 1.2× |
| Q4 FY08 | 21 Apr 2008 | +4.6% | -7.7% | -3.4% | 2.0× |
| Q3 FY08 | 18 Jan 2008 | -6.0% | -23.4% | -34.9% | 1.6× |
| Q2 FY08 | 26 Oct 2007 | +4.7% | -7.9% | -7.3% | 0.8× |
| Q1 FY08 | 28 Jul 2007 | +3.5% | +6.3% | +0.4% | 0.7× |
| Q4 FY07 | 26 Apr 2007 | -1.4% | -1.6% | -6.1% | 3.4× |
| Average | -0.7% | -1.4% | -1.2% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q3 FY25
CSVRevenue YoY+11.8%
Profit YoY+11.4%
Interest cost YoY-37.5%
Revenue QoQ-0.2%
Profit QoQ-0.3%
| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | +16.1% | +9.5% | — | +12.0% | +16.2% | — |
| Profit | +43.3% | +19.3% | — | +20.6% | +65.5% | — |
Key data
CSVOpen573.00
Day range569.80 – 584.90
52-week range376.05 – 774.70
From 52w high-25.5%
RSI (14)38.5
ATR (14)22.95
Volume1.40L
Avg volume (20D)1.50L
Rel volume0.94×
Volatility (1Y)44.0%
Turnover₹8.1Cr
SMA 50 / 200619.78 / 532.73
Delivery percentage
Latest · 6 Oct 202646.2%
20-day avg41.3%
1-year avg36.7%
Percentile (own history)45th
Range6.7–100.0%
Sessions1,731
Over the last 20 sessions VIMTALABS settled 41.3% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 36.7%, so recent sessions are running 4.6 points higher than usual. The latest session ranks higher than 45% of the 1,731 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
IndustryHealthcare Research Analytics & Technology
Performance returns
CSV| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | +0.99% | -1.36% | -11.48% | +4.40% | +41.19% | -20.76% |
Valuation
CSVMarket cap₹2,581 Cr
P/E (TTM)32.4
EPS (TTM)17.82
Shares outstanding4.44Cr
Listed15 Dec 2005
Ownership
CSVPromoter35.67%
Promoter Δ QoQ-0.18 pp
Public64.33%
FII4.42%
DII0.37%
Pledged0.00%
Quarterly results · consolidated
CSV| Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | |
|---|---|---|---|---|
| Revenue (₹ Cr) | 79.7 | 81.8 | 84.7 | 89.9 |
| YoY chg | -2.6% | -2.1% | +15.4% | +10.1% |
| Net profit (₹ Cr) | 12.4 | 12.3 | 15.2 | 21.5 |
| YoY chg | -2.6% | +0.7% | +140.9% | +112.2% |
| Net margin | 15.5% | 15.0% | 18.0% | 23.9% |
| EPS | 2.75 | 2.73 | 3.38 | 4.78 |
Shareholding over time
CSVBy quarter
30 Jun 2026 · promoter 35.67% · public 64.33%2021-092026-06
- Promoter
- Public and others
- Promoter
- 35.67%
- Public
- 64.33%
- Promoter change
- -0.18 pp
- Filed
- 20 Jul 2026
- FII
- 4.42%
- DII
- 0.37%
- Promoter pledged
- 0.00%
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.
Financials · quarterly statement
CSV₹ crore, as filed
| Q3 FY22 | Q4 FY22A | Q2 FY23 | Q3 FY23 | Q4 FY23A | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24A | Q1 FY25 | Q2 FY25 | Q3 FY25 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 67.3 | 74.1 | 79.9 | 77.4 | 81.8 | 83.5 | 73.4 | 81.7 | 79.7 | 81.8 | 84.7 | 89.9 | |
| Other income | 0.7 | 0.4 | 0.8 | 1.1 | 0.7 | 0.6 | 2.0 | 0.9 | 0.5 | 0.7 | 0.7 | 1.2 | |
| Total income | 68.1 | 74.5 | 80.6 | 78.5 | 82.5 | 84.1 | 75.4 | 82.6 | 80.2 | 82.4 | 85.4 | 91.1 | |
| Total expenses | 52.6 | 58.3 | 62.9 | 64.4 | 65.9 | 67.8 | 67.1 | 69.1 | 63.9 | 65.9 | 63.5 | 67.2 | |
| └ Finance costs | 0.2 | 0.6 | 0.8 | 0.7 | 0.2 | 0.4 | 0.6 | 0.5 | 0.5 | 0.5 | 0.4 | 0.6 | |
| └ Depreciation | 5.6 | 6.7 | 7.6 | 7.8 | 8.0 | 8.5 | 8.9 | 8.7 | 8.1 | 8.2 | 8.3 | 9.8 | |
| Profit before tax | 15.5 | 16.2 | 17.8 | 14.1 | 16.6 | 16.3 | 8.4 | 13.5 | 16.3 | 16.5 | 21.9 | 23.9 | |
| Tax expense | 3.8 | 4.4 | 4.5 | 3.8 | 3.9 | 4.1 | 2.1 | 3.4 | 3.9 | 4.2 | 4.9 | 6.4 | |
| Net profit | 11.7 | 11.8 | 13.2 | 10.2 | 12.7 | 12.2 | 6.3 | 10.1 | 12.4 | 12.3 | 15.2 | 21.5 | |
| EPS | 2.64 | 2.68 | 2.98 | 2.31 | 2.87 | 2.75 | 1.43 | 2.29 | 2.79 | 2.77 | 3.44 | 4.83 | |
| Net margin | 17.35% | 15.97% | 16.54% | 13.23% | 15.50% | 14.61% | 8.62% | 12.40% | 15.50% | 15.02% | 17.99% | 23.90% | |
| PBT margin | 22.98% | 21.90% | 22.24% | 18.19% | 20.23% | 19.53% | 11.43% | 16.53% | 20.43% | 20.21% | 25.83% | 26.60% | |
| Tax rate | 24.52% | 27.07% | 25.61% | 27.26% | 23.38% | 25.18% | 24.57% | 24.98% | 24.15% | 25.68% | 22.27% | 26.76% |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 24 Jan 2025.
VIMTALABS at a glance
- VIMTALABS closed at ₹577.4 on 6 Oct 2026, +0.99% on the day, -20.8% over one year, 25.5% below its 52-week high of ₹774.7.
- Delivery was 46.2% of traded quantity on 6 Oct 2026, the 45th percentile of its own 1,731 sessions with a reading (20-session average 41.3%, 1-year average 36.7%).
- Market capitalisation is ₹2,581 crore at a trailing P/E of 32.4 (trailing EPS ₹17.82).
- Q3 FY25 results (consolidated, filed 24 Jan 2025): revenue ₹90 crore (+10.1% year on year), net profit ₹21 crore (+112.2%); the price moved -4.6% on the first session after.
- Promoters held 35.67% at 30 Jun 2026, down 0.18 percentage points on the previous filing.
- Q2 FY27 results are expected between 23 Oct 2026 and 8 Nov 2026, going by past filing dates — an estimate, not an announcement.
About
CSVMacro sectorHealthcare
Basic industryHealthcare Research Analytics & Technology
ISININE579C01029
SeriesEQ
Listed15 Dec 2005
History from15 Dec 2005
Sessions5,152
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.
More in Healthcare Services
CSV- APOLLOHOSPApollo Hospitals Enterprise Limited7,914.50-0.88%
- MAXHEALTHMax Healthcare Institute Limited902.50-1.58%
- FORTISFortis Healthcare Limited764.00+0.03%
- YATHARTHYatharth Hospital & Trauma Care Services Limited1,058.80+5.56%
- ASTERDMAster DM Quality Care Limited684.70-0.98%
- MANIPALHOSManipal Health Enterprises Limited690.50+3.52%
- LALPATHLABDr. Lal Path Labs Ltd.1,964.20-0.36%
- ARTEMISMEDArtemis Medicare Services Limited318.35-1.77%
- NEPHROPLUSNephrocare Health Services Limited634.55-0.49%
- GKSLGujarat Kidney And Super Speciality Limited193.62+1.72%
- KIMSKrishna Institute of Medical Sciences Limited693.40-1.71%
- NHNarayana Hrudayalaya Ltd.1,723.80+0.08%
All Healthcare Services stocks on the NSEAll Healthcare stocks on the NSE